What is ARRY’s business all about? #msg-35321638 2Q09 Earnings CC Transcript #msg-34770721 12 Jan 2009 JP Morgan webcast tidbits/updated pipelines #msg-34695577 09 Jan 2009 Corporate initiatives to streamline operations #msg-33343730 1Q/09 Transcript #msg-31418933 4Q/08 & YE CC Transcript (8/12/08) #msg-29098907 3Q08 CC Transcript (5/6/08) #msg-27628473 Quick primer by ThomasS #msg-27846565 20 March Lehman presentation: selected slides/2008 Pipeline #msg-30550565 08 July Collins Stewart presentation notes
Partnered Programs
ARRY-886 (AZD 6244 with Astra-Zeneca) #msg-29567966 2008 ASCO abstracts presented by AZN #msg-29601974 Further color on probability of success for (ThomasS) #msg-29368807 ARRY 886 further development plans announced (5/15/08)
ARRY-797 #msg-29120848 ARRY-797 additional data presented at APS (5/7/08) #msg-29658325 ARRY-797 and inflammation pathways #msg-29979956 EULAR presentation #msg-31359282 BAC Conference data release update vs. Celebrex #msg-33123222 PII data presented at the 2008 ACR/ARHP (10/26/08)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.